Jennings H J, Roy R, Michon F
J Immunol. 1985 Apr;134(4):2651-7.
A meningococcal group B-specific horse antiserum contains at least two distinct populations of antibodies with specificities for determinants on the group B capsular polysaccharide antigen. These two populations were differentiated on the basis of the ability of only one of them to be absorbed from the antiserum by the structurally related colominic acid. The nature of the colominic acid-specific determinant was elucidated by a radioimmunoassay inhibition technique with the use of a series of linear alpha-(2----8)-linked oligomers of sialic acid as inhibitors. Colominic acid was labeled by prior removal of its N-acetyl groups, followed by their replacement with the use of [3H]acetic anhydride. The conformational nature of the determinant was proposed because of the unusually large size (10 sialic acid residues) of the oligomer required to function as an efficient inhibitor. The structure of the determinant responsible for the second population of group B-specific antibodies has not been determined, but it is obviously based on an as yet undefined conformational or structural feature peculiar to the group B meningococcal polysaccharide. In contrast to the colominic acid-specific group B determinant, the determinant responsible for the group C polysaccharide-specific rabbit antibodies proved to be more conventional. Inhibitory properties of the alpha-(2----9)-linked oligomers maximized with those containing four or five sialic acid residues, which is consistent with the approximate estimated maximal size of an antibody site.
一种B群脑膜炎球菌特异性马抗血清含有至少两种不同的抗体群体,它们对B群荚膜多糖抗原上的决定簇具有特异性。这两种群体是根据其中只有一种能够被结构相关的大肠菌素酸从抗血清中吸收的能力来区分的。通过使用一系列唾液酸的线性α-(2→8)连接的低聚物作为抑制剂的放射免疫测定抑制技术,阐明了大肠菌素酸特异性决定簇的性质。大肠菌素酸通过预先去除其N-乙酰基,然后用[3H]乙酸酐进行取代来进行标记。由于作为有效抑制剂所需的低聚物尺寸异常大(10个唾液酸残基),因此提出了决定簇的构象性质。负责B群特异性抗体第二种群体的决定簇结构尚未确定,但显然是基于B群脑膜炎球菌多糖特有的尚未确定的构象或结构特征。与大肠菌素酸特异性B群决定簇相反,负责C群多糖特异性兔抗体的决定簇被证明更为常规。α-(2→9)连接的低聚物的抑制特性在含有四个或五个唾液酸残基的低聚物中达到最大值,这与抗体结合位点的大致估计最大尺寸一致。